Overview

Intraarticular Dextrose Prolotherapy for Symptomatic Knee Osteoarthritis

Status:
Not yet recruiting
Trial end date:
2023-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this research is to learn more about treating Symptomatic Knee Osteoarthritis (OA) with an ultrasound-guided hypertonic dextrose injection. Researchers would like to determine best practice for injection frequency and effectiveness of the dextrose injection for symptomatic knee OA.
Phase:
Phase 2
Details
Lead Sponsor:
Mayo Clinic